Table 3. Incidence of Endpoints During the Study.
A p<0.05 was considered statistically significant
Outcome | Low-dose group(n = 57) | High-dose group(n = 43) | p value |
---|---|---|---|
Atrial Fibrillation | 5/55(9%) | 0/41(0%) | <0.05 |
New Atrial Fibrillation | 1/49(2%) | 0/37(0%) | N.S. |
Recurrent Atrial Fibrillation | 4/6(67%) | 0/4(0%) | <0.05 |